e-learning
resources
Virtual 2020
Pre-Congress Content
Molecular alterations and immunology in lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Biomarkers of lung cancer based on the expression of genes, transposons and repetitive elements
M. Arroyo Varela (Malaga, Spain), E. Salcedo Lobera (Malaga, Spain), R. Larrosa Jiménez (Malaga, Spain), M. Claros Díaz (Malaga, Spain), R. Bautista Moreno (Malaga, Spain)
Source:
Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Session:
Molecular alterations and immunology in lung cancer
Session type:
E-poster session
Number:
1652
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Arroyo Varela (Malaga, Spain), E. Salcedo Lobera (Malaga, Spain), R. Larrosa Jiménez (Malaga, Spain), M. Claros Díaz (Malaga, Spain), R. Bautista Moreno (Malaga, Spain). Biomarkers of lung cancer based on the expression of genes, transposons and repetitive elements. 1652
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Definition and history of sarcoidosis
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Correlation in expression change between transposons and adjacent genes reveal importance of genomic location in lung cancer.
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019
Identification of the mobile elements differentially expressed in lung cancer
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
Polymorphisms in telomere maintenance genes and risk of lung cancer
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009
Metal elements as early biomarkers of lung cancer
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019
Identification of reference genes in lung cancer from RNA-seq data
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Differential expression analysis of lncRNA in different types of lung cancer
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021
Polymorphisms in cancer-related pathway genes and lung cancer
Source: Eur Respir J 2016; 48: 1184-1191
Year: 2016
LSC - 2017 - Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
DNA methylation markers of surfactant proteins in lung cancer
Source: Annual Congress 2007 - Novel mediators of cellular pathology
Year: 2007
LSC - 2020 - Transcriptome signatures of tobacco carcinogens hint the alteration of TAF6 as a specific feature in smokers lung cancer
Source: Virtual Congress 2020 – Novel methods, diagnostics and biomarkers of chronic lung diseases
Year: 2020
Where next for lung cancer gene expression profiling?
Source: Eur Respir J 2007; 30: 5-6
Year: 2007
Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: ERS Lung Science Conference 2017
Year: 2017
Alteration patterns of tobacco carcinogens in lung adenocarcinoma reveal novel KRAS-addicted candidate oncogenes
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
Lung cancer biomarkers based on miRNA
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021
Comparative gene expression analysis in lung cancer
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Identifying a tissue specific microRNA molecular signature in lung cancer
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021
Defining lineage relationships of multiple lung tumors through shared large genomic rearrangements
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Which gene expression signatures in pharmacogenomic strategies for lung cancer?
Source: Annual Congress 2010 - Customised chemotherapy for lung cancer
Year: 2010
Recognition of aberrant promoter methylation for early diagnosis of lung cancer patients
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept